News
If climate volatility really is the new normal, I told myself, I need more than bank balances and air-conditioned comfort—I ...
In April 2024, Norgine submitted an application for approval of eflornithine in high-risk neuroblastoma (HRNB), via Project Orbis in Australia, Switzerland and the United Kingdom. This milestone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results